Screener
CytomX Therapeutics CTMX Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from CytomX Therapeutics’s reported figures.
Based on the most recent quarter.
The source filing: CytomX Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337950
FAQ
- What is CytomX Therapeutics's debt-to-equity?
- CytomX Therapeutics (CTMX) reported debt-to-equity of 0× in Q2 2026.
- How has CytomX Therapeutics's debt-to-equity changed year-over-year?
- CytomX Therapeutics's debt-to-equity decreased by 67.1% year-over-year, from 0.1× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about CytomX Therapeutics's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude